ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2413

Contributors to Walking Disability in People with Osteoarthritis: Results from a Population-Based Cohort

Lauren King1, Tetyana Kendzerska1,2,3 and Gillian Hawker1,2,3, 1Department of Medicine, University of Toronto, Toronto, ON, Canada, 2Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 3Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, ON, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cardiovascular disease, Disability, morbidity and mortality, osteoarthritis and physical function

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Osteoarthritis - Clinical Aspects Poster II: Biomarkers, Biomechanics and Health Services Research

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoarthritis (OA) is associated with functional limitations, including difficulty walking. However, comorbid disease is common in people with OA and may also be associated with functional limitations; this includes chronic conditions such as obesity, stroke, angina, heart failure, diabetic neuropathy, and intermittent claudication. Previous studies have demonstrated that walking disability is associated with cardiovascular (CV) events and all-cause mortality. Our aim was to examine the extent to which knee and hip OA contribute to walking disability. 

Methods: A population cohort aged ≥55 years was recruited from one urban and one rural community from 1996-98. Age, sex, height and weight, joint complaints, functional limitations and self-reported medical comorbidities known to be associated with walking disability were collected by questionnaire. Subjects with inflammatory arthritis, rheumatic disease, amputation and/or reported use of a wheelchair were excluded. OA was defined as (1) swelling, pain, or stiffness in any joint lasting 6 weeks in the past 3 months; and (2) indication on the homunculus that a knee and/or hip was “troublesome”. Walking disability was defined as self-reported difficulty standing or walking in the last 3 months. Participants were classified into 4 mutually exclusive joint groups based on the presence/absence of knee and hip OA. Using logistic regression, we assessed the independent correlates of walking disability. Covariates of interest were: combined knee and hip OA, knee OA only, hip OA only, neurological disease, CV disease, diabetes and peripheral vascular disease. 

Results: 20,644 participants were included: mean age 68.2±8.5 years, 58.5% female, 51.8% rural-dwelling and mean body mass index (BMI) of 25.9±4.5 kg/m2.  Self-reported walking disability was present in 5,667 (27.5%) subjects. In bivariate analysis, presence of walking disability was associated with increased age, female sex, higher BMI and all covariates of interest (p<0.01). In the final regression analysis, walking disability was significantly associated with older age (odds ration [OR] 1.04, 1.04 – 1.05, p<0.01), sex (OR 0.83, 0.77 – 0.89, p<0.01), BMI (OR 1.07, 1.07 – 1.08, p<0.01), presence of CV disease (OR 2.12, 1.88 – 2.36, p<0.01), diabetes (OR 1.48, 1.28 – 1.71, p<0.01), peripheral vascular disease (OR 6.98, 3.46 – 14.06, p<0.01) and neurological diseases (OR 3.67, 2.58 – 5.20, p<0.01). Controlling for all of these factors, knee and hip OA remained significantly associated with walking disability: knee and hip OA (OR 17.50, 15.33 – 19.97, p<0.01), knee OA only (OR 6.66, 6.03 – 7.37, p<0.01) and hip OA only (OR 7.13, 6.15 – 8.27, p<0.01). 

Conclusion: In a large population cohort aged ≥55 years, the greatest independent contributor to walking disability was the presence of symptomatic knee and hip OA. Given the previously documented relationship between walking disability and mortality, addressing OA-associated functional limitations is important in the management of other common chronic conditions.


Disclosure: L. King, None; T. Kendzerska, None; G. Hawker, None.

To cite this abstract in AMA style:

King L, Kendzerska T, Hawker G. Contributors to Walking Disability in People with Osteoarthritis: Results from a Population-Based Cohort [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/contributors-to-walking-disability-in-people-with-osteoarthritis-results-from-a-population-based-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/contributors-to-walking-disability-in-people-with-osteoarthritis-results-from-a-population-based-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology